Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. (Q39681139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Randolph N Christensen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Rebecca T Marquez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Sarmistha Bandyopadhyay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Erik B Wendlandt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Kathy Keck

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Brandon A Hoffer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Warren N Schmidt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Anton P McCaffrey

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

1 reference

12 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1727-1736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625373%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.126

7 February 2020

exact match

0 references

cites work

In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Dynamics of Hepatitis C Virus Replication in Human Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Cellular cofactors affecting hepatitis C virus infection and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Interferon modulation of cellular microRNAs as an antiviral mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Real-time detection system for quantification of hepatitis C virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Grading and staging systems for inflammation and fibrosis in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Anti-TGF-beta strategies for the treatment of chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Mechanisms of TGF-beta-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

SMAD proteins control DROSHA-mediated microRNA maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

inferred from DOI database lookup

7 January 2021

based on heuristic

Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126

inferred from DOI database lookup

7 January 2021

based on heuristic

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.126